Literature DB >> 19142871

Hypoxia increases normal prostate epithelial cell resistance to receptor-mediated apoptosis via AKT activation.

Sinead Walsh1, Catherine Gill, Amanda O'Neill, John M Fitzpatrick, R William G Watson.   

Abstract

The aging prostate is associated with changes in its vascular structure, which could lead to changes in oxygen levels. Hypoxia is an important environmental change that leads to the progression of many cancers mediated through a number of cellular changes, which included resistance to apoptosis. The role of hypoxia in initiating tumour development has not been previously investigated. We demonstrate that normal prostate epithelial cells develop a resistance to receptor-mediated apoptosis following 24 hr of 1% hypoxia. This effect is associated with the altered expression of a number of pro- and anti-apoptotic proteins, which leads to inhibition of Cytochrome c release and downstream caspase activation. This is mediated via decreased Bax translocation and upstream Caspase 8 activity. Despite increased expression of cIAP-2, small interfering RNA (siRNA) knockdown does not restore susceptibility to TRAIL-induced apoptosis. Gene expression analysis indicated potential changes in AKT activation, which was confirmed by increased phosphorylation of AKT. Inhibition of this phosphorylation reversed the resistance to TRAIL-induced apoptosis. AKT activation is emerging as a key survival signal in prostate cancer. This study demonstrates that short exposure to low oxygen can increase resistance to immune surveillance mechanisms and might confer a survival advantage onto normal prostate epithelial cells so that they can survive subsequent genomic instability and other carcinogenetic insults leading to the early development of prostate cancer.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19142871     DOI: 10.1002/ijc.24145

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  6 in total

1.  Characterisation and manipulation of docetaxel resistant prostate cancer cell lines.

Authors:  Amanda J O'Neill; Maria Prencipe; Catherine Dowling; Yue Fan; Laoighse Mulrane; William M Gallagher; Darran O'Connor; Robert O'Connor; Aoife Devery; Claire Corcoran; Sweta Rani; Lorraine O'Driscoll; John M Fitzpatrick; R William G Watson
Journal:  Mol Cancer       Date:  2011-10-07       Impact factor: 27.401

Review 2.  Aging of the progenitor cells that initiate prostate cancer.

Authors:  Jack Freeland; Preston D Crowell; Jenna M Giafaglione; Paul C Boutros; Andrew S Goldstein
Journal:  Cancer Lett       Date:  2021-05-28       Impact factor: 8.679

3.  The role of epithelial-mesenchymal transition drivers ZEB1 and ZEB2 in mediating docetaxel-resistant prostate cancer.

Authors:  Karen Hanrahan; Amanda O'Neill; Maria Prencipe; Jane Bugler; Lisa Murphy; Aurelie Fabre; Martin Puhr; Zoran Culig; Keefe Murphy; R William Watson
Journal:  Mol Oncol       Date:  2017-01-30       Impact factor: 6.603

4.  Hypoxic non-small-cell lung cancer cell-derived exosomal miR-21 promotes resistance of normoxic cell to cisplatin.

Authors:  Caijun Dong; Xingwang Liu; Huisheng Wang; Jutao Li; Lei Dai; Jun Li; Zhen Xu
Journal:  Onco Targets Ther       Date:  2019-03-12       Impact factor: 4.147

Review 5.  Assessment of tumour hypoxia for prediction of response to therapy and cancer prognosis.

Authors:  Adrian M Jubb; Francesca M Buffa; Adrian L Harris
Journal:  J Cell Mol Med       Date:  2009-10-16       Impact factor: 5.310

6.  Overcoming hypoxic-resistance of tumor cells to TRAIL-induced apoptosis through melatonin.

Authors:  You-Jin Lee; Ju-Hee Lee; Ji-Hong Moon; Sang-Youel Park
Journal:  Int J Mol Sci       Date:  2014-07-04       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.